- IN₹54.31bn
- IN₹63.48bn
- IN₹19.29bn
- 56
- 21
- 78
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.33 | ||
| Price to Tang. Book | 4.41 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.82 | ||
| EV to EBITDA | 13.19 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.75% | ||
| Return on Equity | 16.86% | ||
| Operating Margin | 18.54% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 6,105.06 | 8,286 | 15,509.41 | 21,884 | 19,291.92 | n/a | n/a | 33.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -9.99 | +150.73 | +39.73 | -44.57 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Epigral Limited, formerly Meghmani Finechem Limited, is an India-based manufacturer of essential chemicals. The Company is engaged in manufacturing and selling chlor alkali and its derivatives. It is also engaged in the trading of agrochemical products. The Company manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.
Directors
- Jayanti Patel CHM (63)
- Dinesh Shah VFN (47)
- Sahaj Gautam VPR (53)
- Kamlesh Mehta GMG
- Karna Patel OTH (26)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- September 11th, 2007
- Public Since
- August 18th, 2021
- No. of Employees
- 936
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
National Stock Exchange of India- Shares in Issue
- 41,550,158
- Address
- Shree Nivas Society, Paldi, Gujarat, AHMEDABAD, 380015
- Web
- https://www.meghmanifinechem.com/
- Phone
- +91 7929709600
- Auditors
- S R B C & CO LLP
Upcoming Events for EPIGRAL
Similar to EPIGRAL
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 19:07 UTC, shares in Epigral are trading at IN₹1,307.20. This share price information is delayed by 15 minutes.
Shares in Epigral last closed at IN₹1,307.20 and the price had moved by +36.76% over the past 365 days. In terms of relative price strength the Epigral share price has outperformed the S&P BSE 100 Index by +5.06% over the past year.
There is no consensus recommendation for this security.
The Epigral dividend yield is 0.38% based on the trailing twelve month period.
Last year, Epigral paid a total dividend of IN₹5.00, and it currently has a trailing dividend yield of 0.38%. We do not have any data on when Epigral is to next pay dividends.
We do not have data on when Epigral is to next pay dividends. The historic dividend yield on Epigral shares is currently 0.38%.
To buy shares in Epigral you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,307.20, shares in Epigral had a market capitalisation of IN₹54.31bn.
Here are the trading details for Epigral:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: EPIGRAL
Based on an overall assessment of its quality, value and momentum Epigral is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Epigral. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +18.45%.
As of the last closing price of IN₹1,307.20, shares in Epigral were trading +28.32% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Epigral PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,307.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Epigral's management team is headed by:
- Jayanti Patel - CHM
- Dinesh Shah - VFN
- Sahaj Gautam - VPR
- Kamlesh Mehta - GMG
- Karna Patel - OTH